Clinical trials
Completed Postoperative Pain trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Menarini Group | 4 |
| Hospital Universitari Vall d'Hebron Research Institute | 3 |
| Hospital Universitario de Gran Canaria Doctor Negrín | 3 |
| Hospital Arquitecto Marcide | 2 |
| Hospital Clinic of Barcelona | 2 |
| Hospital HM Nou Delfos | 2 |
| Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
| Aitziber Fernandez Jimenez | 1 |
| Castilla-La Mancha Health Service | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 51 |
| Pain | 8 |
| Acute Pain | 4 |
| Agnosia | 4 |
| Anxiety Disorders | 4 |
| Chronic Pain | 3 |
| Hemorrhoids | 2 |
| Obesity | 2 |
| Postoperative Complications | 2 |
| Abdominal Injuries | 1 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.